Maharashtra FDA bars sale of two Cadila drugs over branding concerns
Published on: July 11, 2026, 7:33 p.m. | Source: The Economic Times
Maharashtra FDA has seized Cadila Pharmaceuticals drug stock worth Rs 2.45 crore. The action was taken due to similar branding on different active ingredients. Officials barred sales of Aciloc 150 Plus and Aciloc 300 Plus medicines. This move aims to prevent medication errors and safeguard public health. Further investigation and legal action are currently underway.
